Security key
457637502
InMed Pharmaceuticals Inc. - Common Stock (INM)
CUSIP: 457637502
Q2 2021 13F Holders as of 30 Jun 2021
- Security type / class
- Equity / Common Stock
- Total 13F shares
- 943,601
- Total 13F value
- $2,986,625
- Share change
- +485,570
- SEC-reported price per share
- $3.18
- Number of holders
- 11
- Value change
- +$1,515,757
- Number of buys
- 4
- Number of sells
- 5
- Shares outstanding
- 737,449
Holder snapshot
6 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q2 2021
Institutions
11
Top holders
10
INM full security history
Ownership snapshot
Full 13F holder table
InMed Pharmaceuticals Inc. SEC filings
InMed Pharmaceuticals Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of INM - InMed Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ARMISTICE CAPITAL, LLC
Disclosed value leader
ARMISTICE CAPITAL, LLC
Comparable rows
15/15
Latest evidence
31 Mar 2021
13F
Lead comparable stake: 32%
Showing 1-6 of 15 holder rows.
Quick read
ARMISTICE CAPITAL, LLC leads the comparable SEC ownership view at 32%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ARMISTICE CAPITAL, LLC's linked filing trail.
Comparable ownership
Top 5
ARMISTICE CAPITAL, LLC
32%
Hudson Bay Capital Management LP
22%
CITADEL ADVISORS LLC
2.3%
BANK OF AMERICA CORP /DE/
2.2%
MORGAN STANLEY
1.7%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC |
13F
Company
|
32%
|
$776,000
235,000 shares
|
— | 31 Mar 2021 |
| Hudson Bay Capital Management LP |
13F
Company
|
22%
|
$531,000
161,000 shares
|
— | 31 Mar 2021 |
| CITADEL ADVISORS LLC |
13F
Company
|
2.3%
|
$57,000
17,211 shares
|
— | 31 Mar 2021 |
| BANK OF AMERICA CORP /DE/ |
13F
Company
|
2.2%
|
$53,000
16,120 shares
|
— | 31 Mar 2021 |
| MORGAN STANLEY |
13F
Company
|
1.7%
|
$41,000
12,581 shares
|
— | 31 Mar 2021 |
| Creative Planning |
13F
Company
|
1.5%
|
$36,000
10,990 shares
|
— | 31 Mar 2021 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q2 2021
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
11
Shares
943,601
Rows available
11
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q2 2021 vs Q1 2021 Across Filers
Q1 2021 holders
12
Q2 2021 holders
11
Holder diff
-1
| Investor | Q1 2021 Shares | Q2 2021 Shares | Share Diff | Share Chg % | Q1 2021 value | Q2 2021 value | Value change | Value Chg % |
|---|